ArticleFrontiers in public health2024
Crime against women in India: district-level risk estimation using the small area estimation approach.
Article in Frontiers in public health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Problems in accessing healthcare among women in India: a district-level change analysis, 2016-2021.BMC public health · 2026Article
- Gender budgeting in the post-pandemic period: an analysis in the context of health and safety of women in India.Frontiers in public health · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The global prevalence of crimes against women has made it an enduring public health challenge that has persisted over time. The achievement of the 2030 Sustainable Development Goal (SDG) is intricately tied to the actions taken to prevent these crimes as their repercussions directly affect progress across various SDGs. This study aimed to provide a comprehensive examination of the prevalence of crimes against women across districts and states in India, analyzing changes from 2020 to 2022, and subsequently identifying associated factors. Methods: The study is an ecological analysis conducted across all districts of India using the data on crimes against women for the period 2020 and 2022 obtained from the National Crime Records Bureau (NCRB) of India. A small area estimation method was used to obtain district-level relative risks of crime against women for both periods. Hotspot analysis was carried out to identify the current hotspots and coldspots. Further spatial regression was used to identify the factors associated with crimes against women in the year 2022. Results: The results indicated a rise in the reported crime against women cases between 2020 and 2022. The rate of crimes against women at the national level was found to be 57 in the year 2020, whereas, in 2022, it increased to 67. The highest crime rate in the year 2022 was found to be 145 in Delhi, while Nagaland had the lowest crime rate of 5. The relative risk of crime against women varied from 0.046 to 4.68 in 2020, while in 2022, it spanned from 0.02 to 6.10. Significant hotspots were found in parts of Rajasthan, Madhya Pradesh, Haryana, Telangana, and Odisha. The results of the spatial error regression model showed that the sex ratio and the population density of the district have significant associations with the occurrence of crimes against women. Conclusion: The rise in the incidence of crime against women emphasizes the importance of tackling the spatial inequality in relative risk across Indian districts. By thoughtfully addressing this variation and conducting targeted studies in high-risk areas, we can enhance our understanding of the obstacles to implementing effective measures against violence targeting women.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.